Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
Abstract Background Vascular Endothelial Growth Factor (VEGF)‐A‐mediated angiogenesis participates in the pathogenesis of psoriasis, thus inviting the hypothesis that anti‐VEGF‐A therapy could be beneficial in psoriasis. While anti‐angiogenic agents are used in oncology and ophthalmology, these ther...
Saved in:
Main Authors: | Andrea Luengas‐Martinez (Author), Dina Ismail (Author), Ralf Paus (Author), Helen S. Young (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor A inhibition remodels the transcriptional signature of lipid metabolism in psoriasis non‐lesional skin in 12 h ex vivo culture
by: Andrea Luengas‐Martinez, et al.
Published: (2024) -
Assessing the association between psoriasis and cardiovascular ischemia: An investigation of vascular endothelial growth factor, cutaneous angiogenesis, and arterial stiffness
by: Alpana Mohta, et al.
Published: (2023) -
Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling
by: Li Wan, et al.
Published: (2019) -
Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma
by: Priya Dharmalingam, et al.
Published: (2013) -
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
by: Weidemann AK, et al.
Published: (2013)